Close

SVB Leerink Downgrades ChemoCentryx (CCXI) to Market Perform

August 5, 2022 6:42 AM EDT
Get Alerts CCXI Hot Sheet
Price: $51.99 --0%

Rating Summary:
    4 Buy, 10 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 0 | Down: 5 | New: 0
Join SI Premium – FREE

SVB Leerink analyst Joseph Schwartz downgraded ChemoCentryx (NASDAQ: CCXI) from Outperform to Market Perform with a price target of $52.00 (from $64.00).


For an analyst ratings summary and ratings history on ChemoCentryx click here. For more ratings news on ChemoCentryx click here.


Shares of ChemoCentryx closed at $50.43 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades